Bank of Montreal’s Biolase, Inc. BIOL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10,040
| Closed | -$1.96K | – | 4349 |
|
|
2024
Q1 | $1.96K | Buy |
+10,040
| New | +$4.89K | ﹤0.01% | 3791 |
|
|
2023
Q3 | – | Sell |
-340
| Closed | -$2.85K | – | 4345 |
|
|
2023
Q2 | $2.85K | Buy |
+340
| New | +$5.69K | ﹤0.01% | 3879 |
|
|
2022
Q2 | – | Sell |
-14
| Closed | -$13K | – | 4539 |
|
|
2022
Q1 | $13K | Hold |
14
| – | – | ﹤0.01% | 3978 |
|
|
2021
Q4 | $17K | Buy |
14
+7
| +100% | +$8.83K | ﹤0.01% | 3360 |
|
|
2021
Q3 | $12K | Hold |
7
| – | – | ﹤0.01% | 3709 |
|
|
2021
Q2 | $14K | Buy |
7
+3
| +75% | +$5.57K | ﹤0.01% | 3536 |
|
|
2021
Q1 | $10K | Buy |
4
+2
| +100% | +$4.92K | ﹤0.01% | 4391 |
|
|
2020
Q4 | $3K | Buy |
+2
| New | +$1.52K | ﹤0.01% | 4819 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 4237 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 4371 |
|
|
2014
Q3 | – | Hold |
0
| – | -$2K | – | 4476 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 4523 |
|
|
2013
Q4 | – | Sell |
-9
| Closed | -$219K | – | 3966 |
|
|
2013
Q3 | $219K | Sell |
9
-157
| -95% | -$5.06M | ﹤0.01% | 2203 |
|
|
2013
Q2 | $7.28M | Buy |
+166
| New | +$9.28M | 0.01% | 599 |
|
Other funds holding BIOL
Bank of Montreal's BIOL Position: Q2 2024 in Review
Bank of Montreal sold out of Biolase, Inc. (BIOL) in Q2 2024, closing a stake of 10,040 shares — an estimated $1.96K sold.
Bank of Montreal first reported a position in BIOL in Q2 2013 and held it in 10 quarters. The position peaked at $7.28M in Q2 2013. 2 funds tracked by Wall St. Rank hold BIOL as of Q2 2024.
- Bank of Montreal reported no remaining Biolase, Inc. position as of Q2 2024 after selling out during the quarter.
- Bank of Montreal sold 10,040 Biolase, Inc. shares in Q2 2024, an estimated $1.96K.
- Bank of Montreal first reported a position in Biolase, Inc. in Q2 2013 and held it in 10 quarters.
- Bank of Montreal's Biolase, Inc. position peaked at $7.28M in Q2 2013.
- 2 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2024.
Based on Bank of Montreal's 13F filing for Q2 2024, filed 14 Aug 2024.